EX-23.2 9 ex23-2.htm AUDITOR'S CONSENT

 

Exhibit 23.2

 

 

Consent of Independent Registered Public Accounting Firm

 

We hereby consent to the use in the Prospectus constituting a part of this Registration Statement of our report dated February 21, 2023, relating to the financial statements of Mangoceuticals, Inc., which is contained in that Prospectus.

 

We also consent to the reference to us under the caption “Experts” in the Prospectus.

 

/s/ Turner, Stone & Company, L.L.P.  
   
Dallas, Texas  
December 11, 2023